動物用整形外科医薬品の市場規模、シェア、動向分析レポート：製品タイプ別、動物タイプ別、用途別、投与経路別、最終用途別、地域別、セグメント予測、2024年～2030年

動物用整形外科医薬品市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の動物用整形外科医薬品市場規模は、2024年から2030年にかけてCAGR 8.6%で成長し、2030年には28億7,000万米ドルに達する見込みです。

再生医療の出現、獣医療におけるビスコサプリメントの採用増加、ペット保険の利用急増は、市場成長を促進すると予想される主な要因の一部です。市場成長を促進するその他の要因としては、動物医療の進歩が挙げられます。ベーリンガーインゲルハイムと米国動物病院協会（AAHA）が実施した調査によると、犬の5頭に1頭、すなわち全犬種の20％が、生涯に何らかの関節の問題を経験するといいます。動物の大多数は、発育性整形外科疾患（DODs）による変形性関節症（OA）に苦しんでおり、特定の犬種は他の犬種よりも関節が奇形になりやすいです。

獣医療における再生医療は、細胞ベースの治療のような様々なアプローチを含め、病気や損傷を受けた細胞や組織などの正常な機能を回復させることを目的としています。間葉系間質細胞（MSC）、多血小板血漿（PRP）、自己血清製剤の使用は、この分野で顕著です。現在、これらの治療法は犬、馬、猫などの動物の腱、靭帯、関節／軟骨の治療に用いられています。これらの治療は主に調査に基づいており、さらに具体的な臨床報告が進行中です。現在の用途にかかわらず、この獣医学の一分野は、獣医学的疾患の効果的な治療と管理に有望視されています。

ペットの飼い主の多くは、ペットの健康管理にペット保険を選んでいます。USAトゥデイの2024年2月の記事によると、調査対象となったアメリカ人の約26％が、毎月51米ドルから100米ドルを愛犬に費やしていると回答しています。一方、いくつかのペット保険会社は、一定額の処方薬をカバーしています。フェッチ・ペットの投薬補償は、病気と事故に対して一つのプランを提供する保険プランの一つです。このプランでは、先天性疾患や整形外科的疾患のような慢性疾患を含む、対象となる疾患に対するすべての処方薬がカバーされます。北米ペット健康保険協会（NAPHIA）によると、2023年現在、米国では約32億米ドルのペット保険が契約されており、2022年末には米国で約480万匹のペットが保険に加入しています。さらに、フォーブスの推計によると、2023年には、病気や骨折などの課題のために動物病院を緊急受診する場合、約1,000米ドルの費用がかかる可能性があります。

1,000米ドルです。したがって、ペット保険は不測の医療費をカバーするために必要なツールです。

MSCやPRPなどの現在の再生療法は、医薬品のカテゴリーに入る。したがって、FDAはこれらを「細胞ベースの製品」というカテゴリーで規制しています。しかし、これらの治療法には現在までFDAの承認は下りておらず、現在の使用はFDAの治験免除に該当します。さらに、技術の進歩は、革新的な治療や処置を導入することで、獣医整形外科医療に革命をもたらしました。高度な画像診断、遺伝子編集、幹細胞治療などの新技術は、動物の健康においてより正確で効果的な介入を可能にします。これらの技術革新は獣医師の診断・治療能力を向上させ、以前は対処が困難であった症状に対する高度な解決策を提供します。

動物用整形外科医薬品市場レポート・ハイライト

• 動物用整形外科合併症の治療にNSAIDS、ステロイドなどの製品が多く採用されているため、2023年には医薬品分野が46.5%のシェアを占め、市場を独占しました。
• 犬のOA有病率の高さ、市場の採用率の高さ、犬のスポーツ傷害の増加により、犬セグメントは予測期間中に最も速いCAGRで成長すると予想されます。
• OA分野は2023年に最大の市場シェアを占めました。
• しかし、関節炎症/疼痛セグメントは予測期間中に最も速い成長を示すと予測されています。
• 北米は、OA有病率の増加、設備の整った動物医療インフラ、質の高い動物医療に対する政府の支援、米国でのペット飼育の増加により、世界の動物用整形外科医薬品市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 動物用整形外科医薬品市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 動物用整形外科医薬品市場分析ツール
  • ポーターの分析
  • PESTEL分析

第4章 動物用整形外科医薬品市場：製品推定・動向分析

• 動物タイプ別市場シェア、2023年および2030年
• セグメントダッシュボード
• 動物用整形外科医薬品市場：製品展望
• 2018年～2030年の市場規模と予測および動向分析
• 生物学的製剤
• 粘性サプリメント
• 医薬品

第5章 動物用整形外科医薬品市場： 動物タイプ別推定・動向分析

• 動物タイプ別市場シェア、2023年および2030年
• セグメントダッシュボード
• 動物用整形外科医薬品市場：動物種別展望
• 2018年～2030年の市場規模と予測および動向分析
• 犬
• 馬
• その他

第6章 動物用整形外科医薬品市場：用途推定・動向分析

• 用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 動物用整形外科医薬品市場：用途の展望
• 変形性関節症
• 変形性関節症（DJD）
• その他の用途

第7章 動物用整形外科医薬品市場：投与経路の推定・動向分析

• 投与経路の市場シェア、2023年と2030年
• セグメントダッシュボード
• 動物用整形外科医薬品市場：投与経路の展望
• 経口
• 注射可能
• その他

第8章 動物用整形外科医薬品市場：最終用途の推定・動向分析

• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 動物用整形外科医薬品市場：エンドユーザーの展望
• 動物病院
• 獣医クリニック
• その他

第9章 動物用整形外科医薬品市場：地域推定・動向分析

• 動物用整形外科医薬品市場シェア、地域別、2023年および2030年
• 北米
  • 市場推計・予測、2018年-2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業の市場シェア分析
• 企業ヒートマップ分析
• 戦略マッピング
  • 拡大
  • 合併と買収
  • パートナーシップとコラボレーション
  • 新製品の発売
  • 研究開発
• 企業プロファイル
  • Zoetis Inc.
  • Boehringer Ingelheim
  • Elanco Animal Health
  • American Regent, Inc.
  • Merck Animal Health（Merck &Co. Inc）
  • Vetoquinol SA
  • Ceva Sante Animale
  • Virbac
  • Biogenesis Bago
  • Ardent Animal Health LLC.
  • Bioiberica SAU
  • PetVivo Holdings, Inc.（Spryng）
  • Contipro AS
  • VetStem, Inc.
  • Enso Discoveries
  • Contura Vet US
  • T-Cyte Therepeutics
  • MEDREGO LLC
  • Bimeda US
  • Hyalogic
  • Hester Biosciences

List of Tables

• Table 1 List of secondary sources
• Table 2 List of Abbreviations
• Table 3 North America Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
• Table 4 North America Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 5 North America Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 6 North America Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 7 North America Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 8 North America Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 9 U.S. Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 10 U.S. Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 11 U.S. Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 12 U.S. Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 13 U.S. Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 14 Canada Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 15 Canada Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 16 Canada Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 17 Canada Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 18 Canada Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 19 Europe Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
• Table 20 Europe Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 21 Europe Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 22 Europe Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 23 Europe Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 24 Europe Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 25 UK Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 26 UK Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 27 UK Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 28 UK Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 29 UK Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 30 Germany Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 31 Germany Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 32 Germany Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 33 Germany Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 34 Germany Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 35 France Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 36 France Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 37 France Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 38 France Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 39 France Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 40 Italy Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 41 Italy Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 42 Italy Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 43 Italy Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 44 Italy Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 45 Spain Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 46 Spain Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 47 Spain Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 48 Spain Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 49 Spain Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 50 Denmark Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 51 Denmark Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 52 Denmark Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 53 Denmark Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 54 Denmark Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 55 Sweden Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 56 Sweden Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 57 Sweden Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 58 Sweden Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 59 Sweden Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 60 Norway Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 61 Norway Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 62 Norway Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 63 Norway Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 64 Norway Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 67 Asia Pacific Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 68 Asia Pacific Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 69 Asia Pacific Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 70 Asia Pacific Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 71 China Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 72 China Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 73 China Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 74 China Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 75 China Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 76 Japan Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 77 Japan Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 78 Japan Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 79 Japan Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 80 Japan Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 81 India Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 82 India Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 83 India Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 84 India Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 85 India Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 86 Australia Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 87 Australia Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 88 Australia Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 89 Australia Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 90 Australia Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 91 South Korea Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 92 South Korea Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 93 South Korea Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 94 South Korea Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 95 South Korea Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 96 Thailand Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 97 Thailand Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 98 Thailand Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 99 Thailand Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 100 Thailand Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 101 Latin America Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
• Table 102 Latin America Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 103 Latin America Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 104 Latin America Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 105 Latin America Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 106 Latin America Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 107 Brazil Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 108 Brazil Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 109 Brazil Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 110 Brazil Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 111 Brazil Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 112 Mexico Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 113 Mexico Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 114 Mexico Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 115 Mexico Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 116 Mexico Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 117 Argentina Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 118 Argentina Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 119 Argentina Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 120 Argentina Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 121 Argentina Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 122 MEA Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
• Table 123 MEA Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 124 MEA Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 125 MEA Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 126 MEA Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 127 MEA Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 128 South Africa Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 129 South Africa Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 130 South Africa Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 131 South Africa Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 132 South Africa Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 133 Saudi Arabia Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 134 Saudi Arabia Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 135 Saudi Arabia Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 136 Saudi Arabia Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 137 Saudi Arabia Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 138 UAE Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 139 UAE Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 140 UAE Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 141 UAE Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 142 UAE Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
• Table 143 Kuwait Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
• Table 144 Kuwait Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
• Table 145 Kuwait Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
• Table 146 Kuwait Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
• Table 147 Kuwait Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Veterinary Orthopedic Medicines Market Segmentation
• Fig. 2 Disease Epidemiology
• Fig. 3 Information Procurement
• Fig. 4 Data Analysis Models
• Fig. 5 Market Formulation and Validation
• Fig. 6 Data Validating & Publishing
• Fig. 7 Market Snapshot
• Fig. 8 Segment Snapshot (1/2)
• Fig. 9 Segment Snapshot (2/2)
• Fig. 10 Competitive Landscape Snapshot
• Fig. 11 Veterinary Orthopedic Medicines - Market Size and Growth Prospects (USD Million)
• Fig. 12 Veterinary Orthopedic Medicines Market: Industry Value Chain Analysis
• Fig. 13 Veterinary Orthopedic Medicines Market: Market Dynamics
• Fig. 14 Veterinary Orthopedic Medicines Market: PORTER's Analysis
• Fig. 15 Veterinary Orthopedic Medicines Market: PESTEL Analysis
• Fig. 16 Veterinary Orthopedic Medicines Market Share By Product, 2023 & 2030 (USD Million)
• Fig. 17 Veterinary Orthopedic Medicines Market, By Product: Market Share, 2023 & 2030
• Fig. 18 Biologics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 19 Viscosupplements Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 20 Pharmaceuticals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 21 Veterinary Orthopedic Medicines Market Share By Animal type, 2023 & 2030 (USD Million)
• Fig. 22 Veterinary Orthopedic Medicines Market, By Animal type: Market Share, 2023 & 2030
• Fig. 23 Canine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 24 Equine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 25 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 26 Veterinary Orthopedic Medicines Market Share By Application, 2023 & 2030 (USD Million)
• Fig. 27 Veterinary Orthopedic Medicines Market, By Application: Market Share, 2023 & 2030
• Fig. 28 Osteoarthritis Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 29 Degenerative Joint Diseases (DJD) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 30 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 31 Veterinary Orthopedic Medicines Market Share By Route of Administration, 2023 & 2030 (USD Million)
• Fig. 32 Veterinary Orthopedic Medicines Market, By Route of Administration: Market Share, 2023 & 2030
• Fig. 33 Oral Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 34 Injectable Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 35 Veterinary Orthopedic Medicines Market, by End User: Key Takeaways
• Fig. 36 Veterinary Orthopedic Medicines Market, by End User: Market Share, 2023 & 2030
• Fig. 37 Veterinary Hospitals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 38 Veterinary Clinics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 39 Other Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 40 Fig. 39 Veterinary Orthopedic Medicines Market Revenue, by Region, 2023 & 2030 (USD Million)
• Fig. 41 Regional Marketplace: Key Takeaways
• Fig. 42 Regional Marketplace: Key Takeaways
• Fig. 43 North America Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 U.S. Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Canada Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Europe Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 UK Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
• Fig. 48 Germany Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 France Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Italy Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Spain Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Denmark Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Sweden Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Norway Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Asia Pacific Veterinary Orthopedic Medicines Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 56 China Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Japan Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 India Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 South Korea Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Australia Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Thailand Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Latin America Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Brazil Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Mexico Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Argentina Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 MEA Market Estimates and Forecasts, 2018 - 2030
• Fig. 67 KSA Market Estimates and Forecasts, 2018 - 2030
• Fig. 68 UAE Market Estimates and Forecasts, 2018 - 2030
• Fig. 69 South Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 70 Kuwait Market Estimates and Forecasts, 2018 - 2030

Veterinary Orthopedic Medicines Market Growth & Trends:

The global veterinary orthopedic medicines market size is expected to reach USD 2.87 billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The emergence of regenerative medicine, the rise in adoption of viscosupplements in veterinary medicine, and the surge in uptake of pet insurance are some of the major factors expected to propel market growth. Other factors fueling market growth include advancements in veterinary medicine. According to a study conducted by Boehringer Ingelheim and the American Animal Hospital Association (AAHA), 1 in 5 five dogs, i.e., 20% of all dogs, experience some kind of joint issue in their lifetime. A majority of animals suffer from Osteoarthritis (OA) due to Developmental Orthopedic Diseases (DODs), with certain breeds more prone to malformed joints than others.

Regenerative medicine in veterinary medicine aims to restore normal function of diseased or damaged cells, tissues, etc., including different approaches like cell-based therapies. The use of Mesenchymal Stromal Cells (MSCs), Platelet-rich Plasma (PRP), and autologous serum products is prominent in this field. Currently, these therapies are used in the treatment of tendon, ligament, and joint/cartilage in animals like dogs, horses, & cats. These treatments are primarily research-based, and further concrete clinical reports are under progress. Irrespective of the current use, this branch of veterinary medicine is showing promise for effective treatment & management of veterinary diseases.

Most pet owners are opting for pet insurance to manage the health expenses of their pets. According to a February 2024 article by USA Today, around 26% of the Americans surveyed stated they spend between USD 51 and USD 100 a month on their dogs. On the other hand, several pet insurance companies cover a certain amount of prescription medication. Fetch Pet medication coverage is one of the insurance plans that offers a single plan for illnesses and accidents. The plan covers all prescription drugs for covered conditions, including congenital and chronic ailments like orthopedic problems. According to the North American Pet Health Insurance Association (NAPHIA), as of 2023, there were pet insurance policies worth around USD 3.2 billion in the U.S. Comparably, there were around 4.8 million insured pets in the U.S. at the end of 2022, which was a 22% rise since 2021. Moreover, according to Forbes estimates, in 2023, a veterinary emergency visit for challenges, such as ailments or a broken bone, might cost around

USD 1,000. Hence, pet insurance is a necessary tool for covering unforeseen medical expenses.

Current regenerative therapies like MSCs, PRP, etc., fall under the category of drugs. Hence, the FDA regulates them under the category "Cell-based Products"; however, no FDA approval has been given to any of these therapies till now, and the current use falls under FDA investigational exemption. In addition, technological advancements revolutionized veterinary orthopedic medicine by introducing innovative treatments and procedures. Novel technologies, such as advanced imaging, gene editing, and stem cell therapies, enable more precise & effective interventions in animal health. These technological breakthroughs enhance the diagnostic and treatment capabilities of veterinarians, providing advanced solutions for conditions that were previously challenging to address.

Veterinary Orthopedic Medicines Market Report Highlights:

• The pharmaceuticals segment dominated the market with a 46.5% share in 2023 due to the high adoption of products, such as NSAIDS, steroids, etc., in the treatment of veterinary orthopedic complications.
• The canine segment is expected to grow at the fastest CAGR over the forecast period due to the high prevalence of OA in dogs, the high market adoption, and the rise in sports injuries among dogs.
• The OA segment held the largest market share in 2023.
• However, the joint inflammation/pain segment is anticipated to witness the fastest growth over the forecast period.
• North America dominated the global veterinary orthopedic medicines market due to the increasing prevalence of OA, well-equipped veterinary care infrastructure, government support for quality animal care, and increasing pet adoption in the U.S.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Animal Type
  • 1.2.3. Application
  • 1.2.4. Route of administration
  • 1.2.5. End Use
  • 1.2.6. Regional scope
  • 1.2.7. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product
  • 2.2.2. Animal Type
  • 2.2.3. Application
  • 2.2.4. Route of administration
  • 2.2.5. End Use
  • 2.2.6. Regional scope
• 2.3. Competitive Insights

Chapter 3. Veterinary Orthopedic Medicines Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of orthopedic problems
    • 3.2.1.2. Growing uptake of pet insurance
    • 3.2.1.3. Increase in ageing animal population
    • 3.2.1.4. Advancements in veterinary orthopedic medicines
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Shortage of veterinarians
    • 3.2.2.2. High treatment cost
• 3.3. Veterinary Orthopedic Medicines Market Analysis Tools
  • 3.3.1. Porter's Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Veterinary Orthopedic Medicines Market: Product Estimates & Trend Analysis

• 4.1. Animal Type Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Veterinary Orthopedic Medicines Market: Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Biologics
  • 4.5.1. Biologics Market, 2018 to 2030 (USD Million)
• 4.6. Viscosupplements
  • 4.6.1. Viscosupplements Market, 2018 to 2030 (USD Million)
• 4.7. Pharmaceuticals
  • 4.7.1. Pharmaceuticals Market, 2018 to 2030 (USD Million)

Chapter 5. Veterinary Orthopedic Medicines Market: Animal Type Estimates & Trend Analysis

• 5.1. Animal Type Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Veterinary Orthopedic Medicines Market: Animal Type Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Canine
  • 5.5.1. Canine Market, 2018 to 2030 (USD Million)
• 5.6. Equine
  • 5.6.1. Equine Market, 2018 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2018 to 2030 (USD Million)

Chapter 6. Veterinary Orthopedic Medicines Market: Application Estimates & Trend Analysis

• 6.1. Application Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Veterinary Orthopedic Medicines Market: Application Outlook
• 6.4. Osteoarthritis
  • 6.4.1. Osteoarthritis Market, 2018 to 2030 (USD Million)
• 6.5. Degenerative Joint Disease (DJD)
  • 6.5.1. Degenerative Joint Disease (DJD) Market, 2018 to 2030 (USD Million)
• 6.6. Other Applications
  • 6.6.1. Other Applications Market, 2018 to 2030 (USD Million)

Chapter 7. Veterinary Orthopedic Medicines Market: Route of Administration Estimates & Trend Analysis

• 7.1. Route of Administration Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. Veterinary Orthopedic Medicines Market: Route of Administration Outlook
• 7.4. Oral
  • 7.4.1. Oral Market, 2018 to 2030 (USD Million)
• 7.5. Injectable
  • 7.5.1. Injectable Market, 2018 to 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 8. Veterinary Orthopedic Medicines Market: End use Estimates & Trend Analysis

• 8.1. End Use Market Share, 2023 & 2030
• 8.2. Segment Dashboard
• 8.3. Veterinary Orthopedic Medicines Market: End user Outlook
• 8.4. Veterinary Hospitals
  • 8.4.1. Veterinary Hospitals Market, 2018 to 2030 (USD Million)
• 8.5. Veterinary Clinics
  • 8.5.1. Veterinary Clinics Market, 2018 to 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 9. Veterinary Orthopedic Medicines Market: Regional Estimates & Trend Analysis

• 9.1. Veterinary Orthopedic Medicines Market Share, By Region, 2023 & 2030 (USD Million)
• 9.2. North America
  • 9.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.2. U.S.
    • 9.2.2.1. Key Country Dynamics
    • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.2.2.3. Competitive Insights
    • 9.2.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
  • 9.2.3. Canada
    • 9.2.3.1. Key Country Dynamics
    • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.2.3.3. Competitive Insights
    • 9.2.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
• 9.3. Europe
  • 9.3.1. Europe Market Estimates and Forecasts, 2018 - 2030
  • 9.3.2. UK
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.2.3. Competitive Insights
    • 9.3.2.4. UK Market Estimates and Forecasts, 2018 - 2030
  • 9.3.3. Germany
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.3.3. Competitive Insights
    • 9.3.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
  • 9.3.4. France
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.4.3. Competitive Insights
    • 9.3.4.4. France Market Estimates and Forecasts, 2018 - 2030
  • 9.3.5. Italy
    • 9.3.5.1. Key Country Dynamics
    • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.5.3. Competitive Insights
    • 9.3.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
  • 9.3.6. Spain
    • 9.3.6.1. Key Country Dynamics
    • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.6.3. Competitive Insights
    • 9.3.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
  • 9.3.7. Denmark
    • 9.3.7.1. Key Country Dynamics
    • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.7.3. Competitive Insights
    • 9.3.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
  • 9.3.8. Sweden
    • 9.3.8.1. Key Country Dynamics
    • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.8.3. Competitive Insights
    • 9.3.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030
  • 9.3.9. Norway
    • 9.3.9.1. Key Country Dynamics
    • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.9.3. Competitive Insights
    • 9.3.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
• 9.4. Asia Pacific
  • 9.4.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • 9.4.2. Japan
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.2.3. Competitive Insights
    • 9.4.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
  • 9.4.3. China
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.3.3. Competitive Insights
    • 9.4.3.4. China Market Estimates and Forecasts, 2018 - 2030
  • 9.4.4. India
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.4.3. Competitive Insights
    • 9.4.4.4. India Market Estimates and Forecasts, 2018 - 2030
  • 9.4.5. Australia
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.5.3. Competitive Insights
    • 9.4.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
  • 9.4.6. Thailand
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.6.3. Competitive Insights
    • 9.4.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 9.4.7. South Korea
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.7.3. Competitive Insights
    • 9.4.7.4. South Korea Market Estimates and Forecasts, 2018 - 2030
• 9.5. Latin America
  • 9.5.1. Latin America Market Estimates and Forecasts, 2018 - 2030
  • 9.5.2. Brazil
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.5.2.3. Competitive Insights
    • 9.5.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
  • 9.5.3. Mexico
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.5.3.3. Competitive Insights
    • 9.5.3.4. Mexico Market Estimates and Forecasts, 2018 - 2030
  • 9.5.4. Argentina
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Regulatory Landscape/Reimbursement Scenario
    • 9.5.4.3. Competitive Insights
    • 9.5.4.4. Argentina Market Estimates and Forecasts, 2018 - 2030
• 9.6. Middle East and Africa
  • 9.6.1. Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • 9.6.2. South Africa
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.6.2.3. Competitive Insights
    • 9.6.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
  • 9.6.3. Saudi Arabia
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.6.3.3. Competitive Insights
    • 9.6.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • 9.6.4. UAE
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
    • 9.6.4.3. Competitive Insights
    • 9.6.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
  • 9.6.5. Kuwait
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
    • 9.6.5.3. Competitive Insights
    • 9.6.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis by Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Market Share Analysis
• 10.4. Company Heat Map Analysis
• 10.5. Strategy Mapping
  • 10.5.1. Expansion
  • 10.5.2. Mergers & Acquisition
  • 10.5.3. Partnerships & Collaborations
  • 10.5.4. New Product Launches
  • 10.5.5. Research And Development
• 10.6. Company Profiles
  • 10.6.1. Zoetis Inc.
    • 10.6.1.1. Participant's Overview
    • 10.6.1.2. Financial Performance
    • 10.6.1.3. Product Benchmarking
    • 10.6.1.4. Recent Developments
  • 10.6.2. Boehringer Ingelheim
    • 10.6.2.1. Participant's Overview
    • 10.6.2.2. Financial Performance
    • 10.6.2.3. Product Benchmarking
    • 10.6.2.4. Recent Developments
  • 10.6.3. Elanco Animal Health
    • 10.6.3.1. Participant's Overview
    • 10.6.3.2. Financial Performance
    • 10.6.3.3. Product Benchmarking
    • 10.6.3.4. Recent Developments
  • 10.6.4. American Regent, Inc.
    • 10.6.4.1. Participant's Overview
    • 10.6.4.2. Financial Performance
    • 10.6.4.3. Product Benchmarking
    • 10.6.4.4. Recent Developments
  • 10.6.5. Merck Animal Health (Merck & Co. Inc)
    • 10.6.5.1. Participant's Overview
    • 10.6.5.2. Financial Performance
    • 10.6.5.3. Product Benchmarking
    • 10.6.5.4. Recent Developments
  • 10.6.6. Vetoquinol S.A.
    • 10.6.6.1. Participant's Overview
    • 10.6.6.2. Financial Performance
    • 10.6.6.3. Product Benchmarking
    • 10.6.6.4. Recent Developments
  • 10.6.7. Ceva Sante Animale
    • 10.6.7.1. Participant's Overview
    • 10.6.7.2. Financial Performance
    • 10.6.7.3. Product Benchmarking
    • 10.6.7.4. Recent Developments
  • 10.6.8. Virbac
    • 10.6.8.1. Participant's Overview
    • 10.6.8.2. Financial Performance
    • 10.6.8.3. Product Benchmarking
    • 10.6.8.4. Recent Developments
  • 10.6.9. Biogenesis Bago
    • 10.6.9.1. Participant's Overview
    • 10.6.9.2. Financial Performance
    • 10.6.9.3. Product Benchmarking
    • 10.6.9.4. Recent Developments
  • 10.6.10. Ardent Animal Health LLC.
    • 10.6.10.1. Participant's Overview
    • 10.6.10.2. Financial Performance
    • 10.6.10.3. Product Benchmarking
    • 10.6.10.4. Recent Developments
  • 10.6.11. Bioiberica S.A.U
    • 10.6.11.1. Participant's Overview
    • 10.6.11.2. Financial Performance
    • 10.6.11.3. Product Benchmarking
    • 10.6.11.4. Recent Developments
  • 10.6.12. PetVivo Holdings, Inc. (Spryng)
    • 10.6.12.1. Participant's Overview
    • 10.6.12.2. Financial Performance
    • 10.6.12.3. Product Benchmarking
    • 10.6.12.4. Recent Developments
  • 10.6.13. Contipro A.S.
    • 10.6.13.1. Participant's Overview
    • 10.6.13.2. Financial Performance
    • 10.6.13.3. Product Benchmarking
    • 10.6.13.4. Recent Developments
  • 10.6.14. VetStem, Inc.
    • 10.6.14.1. Participant's Overview
    • 10.6.14.2. Financial Performance
    • 10.6.14.3. Product Benchmarking
    • 10.6.14.4. Recent Developments
  • 10.6.15. Enso Discoveries
    • 10.6.15.1. Participant's Overview
    • 10.6.15.2. Financial Performance
    • 10.6.15.3. Product Benchmarking
    • 10.6.15.4. Recent Developments
  • 10.6.16. Contura Vet US
    • 10.6.16.1. Participant's Overview
    • 10.6.16.2. Financial Performance
    • 10.6.16.3. Product Benchmarking
    • 10.6.16.4. Recent Developments
  • 10.6.17. T-Cyte Therepeutics
    • 10.6.17.1. Participant's Overview
    • 10.6.17.2. Financial Performance
    • 10.6.17.3. Product Benchmarking
    • 10.6.17.4. Recent Developments
  • 10.6.18. MEDREGO LLC
    • 10.6.18.1. Participant's Overview
    • 10.6.18.2. Financial Performance
    • 10.6.18.3. Product Benchmarking
    • 10.6.18.4. Recent Developments
  • 10.6.19. Bimeda U.S.
    • 10.6.19.1. Participant's Overview
    • 10.6.19.2. Financial Performance
    • 10.6.19.3. Product Benchmarking
    • 10.6.19.4. Recent Developments
  • 10.6.20. Hyalogic
    • 10.6.20.1. Participant's Overview
    • 10.6.20.2. Financial Performance
    • 10.6.20.3. Product Benchmarking
    • 10.6.20.4. Recent Developments
  • 10.6.21. Hester Biosciences
    • 10.6.21.1. Participant's Overview
    • 10.6.21.2. Financial Performance
    • 10.6.21.3. Product Benchmarking
    • 10.6.21.4. Recent Developments